piracetam has been researched along with 4-aminopyridine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Genovese, N; Klawans, HL | 1 |
| Davis, KL; Hollander, E; Mohs, RC | 1 |
| Andreani, A; Leoni, A; Locatelli, A; Morigi, R; Pietra, C; Rambaldi, M; Villetti, G | 1 |
| Boerrigter, P; Gorji, A; Klitgaard, H; Madeja, M; Margineanu, DG; Siep, E; Speckmann, EJ | 1 |
| Bernardi, G; Bonsi, P; Calabresi, P; Costa, C; De Persis, C; Martella, G; Pisani, A; Pisani, F | 1 |
| Elovic, E; Lombard, L; Zafonte, R | 1 |
| Avoli, M; D'Antuono, M; D'Arcangelo, G; Tancredi, V | 1 |
| Bozdemir, H; Gunay, I; Guven, M; Kahraman, I; Koc, F; Sarica, Y | 1 |
| Bonsi, P; Cuomo, D; Madeo, G; Martella, G; Pisani, A; Platania, P; Sciamanna, G; Tassone, A | 1 |
| Baldelli, P; Benfenati, F; Boido, D; Cesca, F; Farisello, P; Ferrea, E; Valtorta, F | 1 |
| Gajda, Z; Horváth, Z; Kéri, G; Orfi, L; Szántai-Kis, C; Szente, M; Török, R | 1 |
3 review(s) available for piracetam and 4-aminopyridine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
Antispasticity medications: uses and limitations of enteral therapy.
Topics: 4-Aminopyridine; Acetates; Adrenergic alpha-Agonists; Amines; Baclofen; Benzodiazepines; Cyclohexanecarboxylic Acids; Cyproheptadine; Dantrolene; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Glycine; Humans; Muscle Relaxants, Central; Muscle Spasticity; Neuroprotective Agents; Piracetam; Serotonin Antagonists | 2004 |
2 trial(s) available for piracetam and 4-aminopyridine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
10 other study(ies) available for piracetam and 4-aminopyridine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
4-Aminopyridine derivatives with antiamnesic activity.
Topics: 4-Aminopyridine; Alzheimer Disease; Aminopyridines; Amnesia; Animals; Avoidance Learning; Carbon Dioxide; Indoles; Male; Mice; Nootropic Agents; Piracetam | 2000 |
Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Guinea Pigs; Hippocampus; In Vitro Techniques; Levetiracetam; Neural Conduction; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Sodium Channel Blockers; Tetraethylammonium; Tetrodotoxin | 2003 |
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; Dose-Response Relationship, Drug; Epilepsy; Lamotrigine; Levetiracetam; Male; Membrane Potentials; Neocortex; Patch-Clamp Techniques; Piracetam; Pyramidal Cells; Rats; Rats, Wistar; Triazines | 2004 |
Neocortical hyperexcitability in a genetic model of absence seizures and its reduction by levetiracetam.
Topics: 4-Aminopyridine; Age Factors; Animals; Anticonvulsants; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Epilepsy, Absence; Image Enhancement; In Vitro Techniques; Levetiracetam; Models, Genetic; Neocortex; Oscillometry; Piracetam; Rats; Rats, Inbred Strains; Rats, Wistar; Signal Processing, Computer-Assisted; Somatosensory Cortex; Videotape Recording | 2006 |
The actions of lamotrigine and levetiracetam on the conduction properties of isolated rat sciatic nerve.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electrophysiology; Female; In Vitro Techniques; Lamotrigine; Levetiracetam; Neural Conduction; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Rats; Rats, Wistar; Sciatic Nerve; Triazines | 2006 |
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Biophysics; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; GABA Antagonists; In Vitro Techniques; Levetiracetam; Magnesium; Male; Membrane Potentials; Neocortex; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Pyrrolidinones; Rats; Rats, Wistar | 2009 |
Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
Topics: 4-Aminopyridine; Aging; Analysis of Variance; Animals; Anticonvulsants; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Electrodes; Epilepsy, Tonic-Clonic; Evoked Potentials; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Levetiracetam; Membrane Glycoproteins; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Synapsins; Synaptophysin | 2010 |
Protein kinase inhibitor as a potential candidate for epilepsy treatment.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamazepine; Carbenoxolone; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Heart Rate; Levetiracetam; Male; Piracetam; Premedication; Protein Kinase Inhibitors; Rats; Rats, Wistar; Signal Processing, Computer-Assisted | 2011 |